Review Article
Intramyocardial Hemorrhage: An Enigma for Cardiac MRI?
| Study | Type of study | | IMH (%) | Time after MI | MVO (mean %) | IMH assessment | Follow-up | End point |
|
Kidambi A et al. [26] (2013) | Prospective | 39 | 35 | 2 days | 56 | T2-weighted and T2* | 90 days | Infarct contractility |
| Kali et al. [27] (2013) | Prospective | 15 | 73 | 3 days | | T2* | 6 months | Scar tissue |
| Kali et al. [28] (2013) | Prospective | / | 14 | 3 days | | T2 STIR and T2* | Unclear | Hemorrhage |
|
Porto et al. [20] (2007) | Prospective | 52 | 23 | 4–7 days | | T2 W | 6 months | Infarct size myocardial salvage index MVO |
| Mather et al. [29] (2011) | Prospective | 48 | 25 | 2 days | 63 |
T2 W and T2* | 3 months | LVEF, LVES QRS myocardial salvage infarct size |
| Eitel et al. [30] (2011) | Prospective | 346 | 35 | 3 days | 43 | T2-weighted | 6 months | MACE: death, reinfarction congestive heart failure |
| Bekkers et al. [4] (2010) | Prospective | 90 | 43 | 5 ± 2 days | 54 | T2-weighted | 103 ± 11 days | LV remodeling |
| Beek et al. [7] (2010) | Prospective | 45 | 44 | 5.1 ± 2.1 days | 60 | T2-weighted | 4 months | Ejection fraction |
| Ganame et al. [6] (2009) | Prospective | 98 | 25 | 1 week | 64 | T2-weighted | 4 months | LV Adverse remodeling |
| Ochiai et al. [31] (1999) | Prospective | 39 | 33 |
5.7 days | 66 | T2*-weighted gradient-echo | 1 month | LVEF infarct size |
| Asanuma et al. [32] (1997) | Prospective | 24 | 38 | 6 days | 33 | T2*-weighted gradient-echo | 31 days | Wall motion score |
|
|